Kyoko Maruyama

541 total citations
10 papers, 405 citations indexed

About

Kyoko Maruyama is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kyoko Maruyama has authored 10 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Nephrology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kyoko Maruyama's work include Chromosomal and Genetic Variations (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Kyoko Maruyama is often cited by papers focused on Chromosomal and Genetic Variations (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Kyoko Maruyama collaborates with scholars based in Japan, United States and France. Kyoko Maruyama's co-authors include Daniel L. Hartl, Kazumoto Iijima, Kazunori Mizuno, Tatsutoshi Nakahata, Katsuyuki Ohmori, Toshio Heike, Peter D. Emanuel, Ryuta Nishikomori, Kevin Shannon and Pierre Capy and has published in prestigious journals such as Blood, Journal of Molecular Evolution and Pediatric Nephrology.

In The Last Decade

Kyoko Maruyama

10 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyoko Maruyama Japan 9 193 108 81 71 55 10 405
Thomas P. Howard United States 8 460 2.4× 54 0.5× 6 0.1× 42 0.6× 28 0.5× 12 549
Joanna Kosałka-Węgiel Poland 11 155 0.8× 30 0.3× 25 0.3× 140 2.0× 21 0.4× 53 422
Keqin Zheng Canada 10 218 1.1× 44 0.4× 116 1.4× 22 0.3× 95 1.7× 12 438
Tasoula Touloumenidou Greece 9 80 0.4× 64 0.6× 34 0.4× 166 2.3× 8 0.1× 30 395
Gerald A.J. Gillespie United States 9 228 1.2× 20 0.2× 8 0.1× 73 1.0× 161 2.9× 13 372
Geneviève Pont-Kingdon United States 12 189 1.0× 57 0.5× 16 0.2× 11 0.2× 94 1.7× 22 347
Natacha Vitrat France 10 161 0.8× 28 0.3× 33 0.4× 49 0.7× 52 0.9× 12 492
Sarah Irmscher Germany 3 225 1.2× 11 0.1× 16 0.2× 97 1.4× 25 0.5× 4 369
Nicole C.C. Them Austria 6 540 2.8× 38 0.4× 23 0.3× 35 0.5× 14 0.3× 8 821
Havva Keskin Türkiye 12 530 2.7× 62 0.6× 8 0.1× 31 0.4× 47 0.9× 40 686

Countries citing papers authored by Kyoko Maruyama

Since Specialization
Citations

This map shows the geographic impact of Kyoko Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoko Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoko Maruyama more than expected).

Fields of papers citing papers by Kyoko Maruyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyoko Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoko Maruyama. The network helps show where Kyoko Maruyama may publish in the future.

Co-authorship network of co-authors of Kyoko Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Kyoko Maruyama. A scholar is included among the top collaborators of Kyoko Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyoko Maruyama. Kyoko Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Shinmura, Kazuya, Shun Matsuura, Yusuke Inoue, et al.. (2014). A novel somatic FGFR3 mutation in primary lung cancer. Oncology Reports. 31(3). 1219–1224. 9 indexed citations
2.
Matsuura, Shun, Kazuya Shinmura, Takaharu Kamo, et al.. (2013). CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma. Oncology Reports. 30(4). 1675–1680. 22 indexed citations
3.
Inoue, Daichi, Kyoko Maruyama, Kazunari Aoki, et al.. (2011). Blastic Plasmacytoid Dendritic Cell Neoplasm Expressing the CD13 Myeloid Antigen. Acta Haematologica. 126(2). 122–128. 10 indexed citations
4.
Stephens, Karen, Molly Weaver, Kathleen A. Leppig, et al.. (2006). Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood. 108(5). 1684–1689. 52 indexed citations
5.
Nishikomori, Ryuta, Hiroshi Akutagawa, Kyoko Maruyama, et al.. (2004). X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival. Blood. 103(12). 4565–4572. 74 indexed citations
6.
Maruyama, Kyoko, Kazumoto Iijima, Masahiro Ikeda, et al.. (2003). NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children. Pediatric Nephrology. 18(5). 412–416. 49 indexed citations
7.
Maruyama, Kyoko, Hisahide Nishio, Taku Shirakawa, et al.. (2001). Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatric Nephrology. 16(4). 350–355. 43 indexed citations
8.
Hitosugi, Masahito, et al.. (1998). Degree of injury severity of the traffic accident autopsy cases.. Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine. 9(5). 173–181. 1 indexed citations
9.
Maruyama, Kyoko & Daniel L. Hartl. (1991). Evidence for interspecific transfer of the transposable element mariner betweenDrosophila andZaprionus. Journal of Molecular Evolution. 33(6). 514–524. 119 indexed citations
10.
Capy, Pierre, et al.. (1991). Insertion sites of the transposable elementmariner are fixed in the genome ofDrosophila sechellia. Journal of Molecular Evolution. 33(5). 450–456. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026